Recent Press Releases

Bayer HealthCare and Aronora Establish Partnership for the Pre-Clinical Manufacturing of AB-022

Bayer HealthCare and Aronora Establish Partnership for the Pre-Clinical Manufacturing of AB-022 SAN FRANCISCO and BERKELEY, Calif., Feb. 24, 2015 /PRNewswire/ -- Bayer HealthCare and Aronora, Inc....

Medical Drug Re-Packager and Company's Senior Executives Indicted on Fraud Charges and Criminal Violations of the Food, Drug and Cosmetic Act

Earlier today, a 37-count indictment was unsealed in Brooklyn federal court charging Med Prep Consulting, Inc. ("Med Prep"), a Tinton Falls, New Jersey, medical drug re-packager and processer,...

PHARMACEUTICAL COMPANY MOVING ITS MANUFACTURING OPERATIONS TO BLUE ASH

A U.S.-based pharmaceutical company will be bringing new jobs to the City of Blue Ash thanks to the Ohio Jobs Creation Tax Credit. The Ohio Tax Credit Authority approved a 55%, 8-year job creation...

Mylan Signs Exclusive Agreement with Gilead Sciences to Distribute Sovaldi® and Harvoni® in India

PITTSBURGH and HYDERABAD, India, Feb. 23, 2015 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its Indian subsidiary, Mylan Pharmaceuticals Private Limited, has entered into an...

Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Atracurium Besylate Injection, USP, 50mg/5mL and 100mg/10mL Due to FDA Observations Pertaining to Aseptic and GMP Practices at the Manufacturer's Site Potentially Impacting Product Sterilit

SCHAUMBURG, Ill., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of two lots of Atracurium Besylate Injection, USP, 50mg/5mL...

WuXi PharmaTech Enters into Syndicated Loan Agreement

WuXi PharmaTech Enters into Syndicated Loan Agreement SHANGHAI, Feb. 17, 2015 / -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company...

AMRI Announces Fourth Quarter and Full Year 2014 Results

ALBANY, N.Y., Feb. 12, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the fourth quarter and full year ended December 31, 2014. "While our OsoBio...

AMRI Announces Proposal to Close UK-Based API Manufacturing Facility

ALBANY, New York, Feb. 12, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today its intention, subject to consultation with its UK workforce, to close its UK facility in Holywell, Wales, which...

Louisville Physician Pays $515,408.85 for Treating Patients with Misbranded Drugs and Fraudulently Charging Medicare

U.S. Department of Justice Press Release For Immediate Release January 29, 2015 United States Department of Justice Western District of Kentucky LOUISVILLE, Ky. – A Louisville physician pleaded...

Pew, Other Groups Identify Potential Measures to Address Drug Shortages

Pew and other health care organizations released a report on February 5, 2015 exploring measures that should be considered to address the ongoing issue of drug shortages in the United States, which...

Cipla's U.K. subsidiary enters into a joint venture agreement with existing partners – Cooper Pharma and The Pharmaceutical Institute (PHI)

Cipla's U.K. subsidiary enters into a joint venture agreement with existing partners – Cooper Pharma and The Pharmaceutical Institute (PHI) ~ Joint Venture agreement facilitates Cipla with...

Enteris BioPharma Launches Contract Manufacturing within 32,000 Square Foot, FDA inspected and cGMP Compliant Facility

Cost-effective, high-quality production of API using microbial expression systems Boonton, NJ – February 10, 2015 – Enteris BioPharma, Inc., an industry leader in oral peptide delivery,...

Enteris BioPharma Launches Contract Manufacturing within 32,000 Square Foot, FDA inspected and cGMP Compliant Facility

Enteris BioPharma Launches Contract Manufacturing within 32,000 Square Foot, FDA inspected and cGMP Compliant Facility Cost-effective, high-quality production of API using microbial expression...

Juno Therapeutics Establishes Manufacturing Presence in Washington State

Juno Therapeutics Establishes Manufacturing Presence in Washington State SEATTLE, Feb. 9, 2015 (GLOBE NEWSWIRE) -- Juno Therapeutics, Inc. (Nasdaq:JUNO) today announced that it has entered into a...

Cambrex Reports Fourth Quarter and Full Year 2014 Financial Results

Cambrex Reports Fourth Quarter and Full Year 2014 Financial Results 2014 Sales of $374.2 million and EBITDA of $82.1 million significantly exceed guidance Strong sales and EBITDA growth expected...

Cambrex Announces Expansion of Large Scale API Capacity

Cambrex Announces Expansion of Large Scale API Capacity EAST RUTHERFORD, N.J., Feb. 6, 2015 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that it has...

Plasticell wins Innovate UK funding for £1.6 million cord blood stem cell manufacturing project

Plasticell has announced that Innovate UK has made a further investment in a therapeutic programme utilising CombiCult®, the high throughput stem cell technology designed to solve bottlenecks in...

Warwick: New £12 million Synthetic Biology Centre to help drive advances in biotechnology, medicine and food security

Vince Cable, the Secretary of State for Business, Innovation and Skills, announced today Thursday 29th January 2015 that researchers at the Warwick Integrative Synthetic Biology centre (WISB) have...

ICON Creates New Global Innovation Hub in Ireland to Advance Clinical Development

Global Innovation Hub will create 200 Scientific, IT and Business jobs in Ireland Dublin, Ireland, 29th January, 2015 – ICON plc, (NASDAQ: ICLR) a global provider of outsourced development...

Vertellus Completes Purchase of Dow's Sodium Borohydride Business

Vertellus Completes Purchase of Dow's Sodium Borohydride Business INDIANAPOLIS — Feb. 2, 2015 - Vertellus, a global leading producer of specialty chemicals for the life sciences market and...